Differential expression of immune activation markers in T cells from patients with multiple myeloma - Top-Institutions - MDSpire

Differential expression of immune activation markers in T cells from patients with multiple myeloma

  • By

  • Jiaoya Lin

  • Xin Zhang

  • Yifei Zhao

  • Lan Luo

  • Hong Yuan

  • Ling Zhong

  • May 20, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Hematology
    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Hematology
    • Oncology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

Differential expression of immune activation markers in T cells from patients with multiple myeloma

  • by Jiaoya Lin, Xin Zhang, Yifei Zhao, Lan Luo, Hong Yuan, Ling Zhong

  • May 20, 2026

Related Content

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2